Bristol-Myers Squibb Co (NYSE:BMY)

64.66
Delayed Data
As of May 01
 +0.93 / +1.46%
Today’s Change
46.30
Today|||52-Week Range
69.20
+9.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$107.8B

Company Description

Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from biological processes called biologics. The company's biopharmaceutical research and development efforts in the affective (psychiatric) disorders, Alzheimer's/dementia, cardiovascular, diabetes, hepatitis, HIV/Acquired Immunodeficiency Syndrome (AIDS), oncology, immunologic disorders and fibrotic disease areas. Bristol-Myers Squibb was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol-Myers Squibb Co.
345 Park Avenue
New York New York 10154
P:(212) 546-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders40.30%
Other institutional32.84%
Individual stakeholders0.32%

Top Executives

Lamberto AndreottiChairman-Designate & Chief Executive Officer
Giovanni CaforioPresident, CEO-Designate, COO & Director
Charles A. BancroftChief Financial Officer & Executive Vice President
Paul von AutenriedChief Information Officer & Senior Vice President
Francis M. CussChief Scientific Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account